Veteran journalist, investor, and Second Opinion Media founder Chrissy Farr talks with the CEOs and founders who've been in the trenches long enough to know that healthcare doesn't move at startup speed. These aren't the entrepreneurs chasing quick exits—they're the "lifers" who understand that building in healthcare requires endless pivots, regulatory navigation, and decade-long timelines.
No hype, just honest conversations about what it really takes.
Each episode explores healthcare innovation, startup strategy, medical technology and AI, health system transformation, and investment insights from operators who've navigated regulatory challenges, clinical trials, reimbursement complexities, and the unique dynamics of the healthcare industry.
All content for Lifers with Christina Farr is the property of Christina Farr and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Veteran journalist, investor, and Second Opinion Media founder Chrissy Farr talks with the CEOs and founders who've been in the trenches long enough to know that healthcare doesn't move at startup speed. These aren't the entrepreneurs chasing quick exits—they're the "lifers" who understand that building in healthcare requires endless pivots, regulatory navigation, and decade-long timelines.
No hype, just honest conversations about what it really takes.
Each episode explores healthcare innovation, startup strategy, medical technology and AI, health system transformation, and investment insights from operators who've navigated regulatory challenges, clinical trials, reimbursement complexities, and the unique dynamics of the healthcare industry.
Let's talk about men's health: hormones, longevity, and cultural shifts, with Hone CEO Saad Alam
Lifers with Christina Farr
40 minutes
10 months ago
Let's talk about men's health: hormones, longevity, and cultural shifts, with Hone CEO Saad Alam
In this episode of Second Opinion, Christina Farr and Luba Greenwood discuss men's health with Saad Alam, co-founder and CEO of Hone Health. They cover the rapid cultural shift in attitudes toward men's wellness, Alam's personal journey with hormone imbalances, and the emerging trends in health treatments for men, including testosterone therapy and lifestyle changes.
—
📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess
🙏 Help shape our show by taking our quick listener survey at https://bit.ly/TurpentinePulse
—
SPONSOR:
👩⚕️ Hot flashes, insomnia, brain fog? You don't have to accept these as just another part of aging. Midi Health is the virtual care clinic for women navigating midlife hormonal transition, offering FDA-approved medications, supplements and lifestyle coaching - all covered by insurance. Visit https://www.joinmidi.com/ to book your virtual visit today.
—
RECOMMENDED PODCAST:
Check out Modern Relationships, where Erik Torenberg interviews tech power couples and leading thinkers to explore how ambitious people actually make partnerships work. Founders Fund's Delian Asparouhov and researcher Nadia Asparouhova kick off the series with an unfiltered conversation about their relationship evolution.
Apple: https://podcasts.apple.com/us/podcast/id1786227593
Spotify: https://open.spotify.com/show/5hJzs0gDg6lRT6r10mdpVg
YouTube: https://www.youtube.com/@ModernRelationshipsPod
—
LINKS:
Hone Health: https://honehealth.com/
Subscribe to Second Opinion Newsletter: https://secondopinion.media/
—
FOLLOW:
https://www.linkedin.com/in/saad-alam-a146b311/
https://www.linkedin.com/in/christinafarr/
https://www.linkedin.com/in/lubagreenwood/
https://www.linkedin.com/in/ashzenooz/
—
HIGHLIGHTS FROM THE EPISODE:
Saad Alam started Hone Health after personally experiencing dismissive medical care when seeking help for his hormone-related health issues at age 35.
Modern men have 26% less testosterone and 50% fewer sperm compared to men 30 years ago.
Hone's treatment approach starts with lifestyle fundamentals (sleep, hydration, stress, movement) before considering medication.
The company performs comprehensive testing of 50 biomarkers and requires double testing before prescribing treatment.
Men's health stigma has decreased significantly in the past 4-5 years, partly due to influencers normalizing hormone discussions.
Men are increasingly open to wellness treatments like contrast therapy and Botox, with male Botox being the fastest-growing category.
The average Hone patient is 39 years old, significantly younger than the national average testosterone user age of 52.
Men strongly prefer testosterone treatment over weight loss medications, with 80% rejecting weight loss prescriptions.
Urban living is associated with a 30-40% higher likelihood of hormone imbalance due to environmental contaminants.
Hone conducts 45-minute consultations to create a safe space for men to discuss their health concerns openly.
Treatment monitoring includes regular checks for estrogen-related side effects and red blood cell counts.
Environmental factors like plastics, phthalates, and PCBs can significantly disturb hormone production.
The top concerns for male patients are energy, muscles, and libido, while women prioritize brain fog, night sweats, and mood.
The standard starting dose for testosterone treatment is 50-75mg per week, far lower than the 1000-2000mg used by bodybuilders.
Lifers with Christina Farr
Veteran journalist, investor, and Second Opinion Media founder Chrissy Farr talks with the CEOs and founders who've been in the trenches long enough to know that healthcare doesn't move at startup speed. These aren't the entrepreneurs chasing quick exits—they're the "lifers" who understand that building in healthcare requires endless pivots, regulatory navigation, and decade-long timelines.
No hype, just honest conversations about what it really takes.
Each episode explores healthcare innovation, startup strategy, medical technology and AI, health system transformation, and investment insights from operators who've navigated regulatory challenges, clinical trials, reimbursement complexities, and the unique dynamics of the healthcare industry.
